NCT03921203View on ClinicalTrials.gov

ApoB48 Metabolism in Plasma and Interstitial Fluid

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

December 1, 2021

Study Completion Date

December 31, 2022

Conditions
Diabetes Mellitus, Type 2
Trial Locations (1)

14186

Patient research centre, Clinic of endocrinology, Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska University Hospital

OTHER

NCT03921203 - ApoB48 Metabolism in Plasma and Interstitial Fluid | Biotech Hunter | Biotech Hunter